|
Spondylarthropathies
Citations 31-40 of 281 total displayed.
|
Past content
(since Apr 2000):
|
- CLINICAL
Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register
- L. E. Kristensen, P. Geborek, and T. Saxne
Rheumatology 2009; 48: 243-245.
[Abstract]
[Full Text]
- CLINICAL
Health care utilization in patients with spondyloarthropathies
- J. A. Singh and V. Strand
Rheumatology 2009; 48: 272-276.
[Abstract]
[Full Text]
- CLINICAL
Patients with ankylosing spondylitis have increased sick leave—a registry-based case–control study over 7 yrs
- Britta Strömbeck, Lennart T. H. Jacobsson, Ann Bremander, Martin Englund, Anders Heide, Aleksandra Turkiewicz, and Ingemar F. Petersson
Rheumatology 2009; 48: 289-292.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis
- P. Pasquetti, G. Morozzi, and M. Galeazzi
Rheumatology 2009; 48: 315-316.
[Extract]
[Full Text]
- CASE REPORTS
Possible miliary tuberculosis during adalimumab therapy with negative -IFN release assays
- A. L. Endean, S. M. Barry, and S. A. Young-Min
Rheumatology 2009; 48: 319-320.
[Extract]
[Full Text]
- CLINICAL
Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis
- Y.-Y. Leung, L. S. Tam, K. W. Lee, M. H. Leung, E. W. Kun, and E. K. Li
Rheumatology 2009; 48: 53-56.
[Abstract]
[Full Text]
- CLINICAL
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice
- C. D. Poole, P. Conway, and C. J. Currie
Rheumatology 2009; 48: 78-82.
[Abstract]
[Full Text]
- EDITORIALS
What is the most important outcome parameter in ankylosing spondylitis?
- J. Braun and J. Sieper
Rheumatology 2008; 47: 1738-1740.
[Extract]
[Full Text]
- BASIC SCIENCE
Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis
- S. T. Choi, J. H. Kim, E.-J. Kang, S.-W. Lee, M.-C. Park, Y.-B. Park, and S.-K. Lee
Rheumatology 2008; 47: 1775-1779.
[Abstract]
[Full Text]
- BASIC SCIENCE
Lack of association between Tenascin-C gene and spondyloarthritis
- E. Zinovieva, N. Lebrun, F. Letourneur, F.-X. Laurent, R. Said-Nahal, G. Chiocchia, and M. Breban
Rheumatology 2008; 47: 1655-1658.
[Abstract]
[Full Text]
[ Supplementary Data ]
|
|